#France #Avicenna.AI #Avi #Medical Imaging AI #La Ciotat

Avicenna.AI Unveils AVI: A Revolutionary Platform for Medical Imaging AI Integration

On November 13, 2025, Avicenna.AI, a leader in medical imaging AI technology, officially announced the launch of its new platform named AVI. This innovative platform is designed to deliver artificial intelligence results seamlessly into existing healthcare ecosystems, providing a much-needed solution for healthcare organizations looking for efficient imaging AI capabilities.

The core of AVI’s functionality lies in its capacity to offer fast and flexible access to various imaging AI solutions, ensuring that results are seamlessly integrated into clinical workflows. Unlike previous systems that often required significant changes to how clinicians operated, AVI is fully automatic and operates invisibly to the end user. This integration facilitates smooth transitions as it connects directly with existing Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS), eliminating the need for additional viewers, worklists, or workflow modifications.

Cyril Di Grandi, co-founder and CEO of Avicenna.AI, explained that AVI was created to remove barriers to AI adoption within healthcare. He stated, "Fast, automatic, and invisible, AVI is the platform that makes AI work the way it should – no extra training required, no changes to workflow, no new viewers, and no additional clicks." This emphasis on user-friendly integration aims to allow clinicians, radiologists, and healthcare institutions to leverage AI insights without expecting disruptions in their routine operations.

One of the standout features of AVI is its centralized configuration and orchestration, which significantly simplifies IT operations. Healthcare organizations can unlock access to the platform's entire suite of applications through a one-time integration. Initially, AVI will host Avicenna's comprehensive CINA portfolio, which includes advanced AI solutions for detecting severe medical conditions, such as:

• - Intracranial hemorrhage (CINA-ICH)
• - Large vessel occlusion (CINA-LVO)
• - Aortic dissection (CINA-AD)
• - Pulmonary embolism (CINA-PE and CINA-iPE)
• - Vertical compression fractures (CINA-VCF and CINA-VCF Quantix)
• - Cervical spine fractures (CINA-CSpine)
• - ASPECT Score for quantifying stroke severity (CINA-ASPECTS)

With its ability to deliver speed and scalability alongside top performance and quality, AVI is tailored for hospitals, healthcare networks, and teleradiology groups that wish to tap into the transformative power of imaging AI applications. Its plug-and-play design allows for hassle-free AI implementation with minimal spatial requirements. Furthermore, the platform is structured to scale from single facilities to extensive networks, fully compliant with global standards such as DICOM, HL7, and FHIR, ensuring easy integration with existing healthcare systems.

Data security is paramount with AVI; it supports compliance with GDPR and HIPAA regulations. Data undergoes de-identification before processing and is re-identified upon return, ensuring patient privacy through robust encryption, stringent access controls, and auditable operational mechanisms.

Avicenna.AI was established in 2018 with a mission to enhance healthcare AI solutions, notably using deep learning techniques to identify, detect, and quantify critical pathologies from CT images. The company was co-founded by Cyril Di Grandi, a successful entrepreneur with a background in medical imaging, and Dr. Peter Chang, an internationally esteemed radiologist with expertise in artificial intelligence and deep learning.

By providing AI-based radiology solutions, Avicenna.AI aims to expedite therapeutic decision-making processes and improve patient outcomes significantly. For more information about this groundbreaking innovation and to learn about their full array of medical imaging solutions, visit their official website at www.avicenna.ai.